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NATIONAL AND PROVINCIAL
ESTIMATED COSTS AND COST
EFFECTIVENESS OF A PROGRAMME
TO REDUCE MOTHER-TO-CHILD
HIV TRANSMISSION IN SOUTH
AFRICA
R3.89 per capita total population. The cost per DALY gained
compares well with established public health and clinical
interventions in middle-income countries, even without
factoring in the care costs that would be saved through a
successful programme. Cost effectiveness is greatest where
HIV prevalence is highest.
5 Afr Med J2000; 90: 794-798.
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Objective. To estimate the cost and cost effectiveness
nationally and for each province of a programme to reduce
mother-to-child transmission (MTCT) of HIV in South Africa.
Methods. A model developed to estimate cost and cost
effectiveness of interventions in Hlabisa, KwaZulu-Natal,
was modified and applied to each province. This model
predicts a 37% reduction in paediatric HIV infections if short-
course oral zidovudine (ZDV) plus infant formula feed for 4
months is provided within a strengthened health system.
Estimates of the number of pregnancies and HIV prevalence
among pregnant women per province in 1997 were combined
with an estimated 30% MTCT rate. Costs were calculated
from a health system perspective, and effectiveness was
estimated as cost per infection averted and cost per
disability-adjusted life year (DALY) gained.
Results. In 1997, 63 397 paediatric HIV infections were
estimated to have occurred in South Africa, mainly in
KwaZulu-Natal (18 513, 29%) and Gauteng (10 417,16%). The
cost of a national programme is estimated at R155.9 million
(1997 rand costs, 0.94% of the national health budget). Major
cost items are drugs (R46.4m, 30%), staff salaries (R45.8m,
29%), and formula feed (R37.1m, 24%). Most money would
need to be spent in KwaZulu-Natal (R37.6m, 24% of national
cost), Gauteng (R25.2m, 16%) and the Eastern Cape (R24m,
15%). National cost per infection averted is R6 724, and R213
per DALY gained. Provincial DALY costs range from R176 to
R369.
South Africa is suffering from an explosive HIV epidemic,
among the worst in the world/ with HIV prevalence among
pregnant women close to 30% in some areas.' The number of
children infected with HIY, and the incidence of illness in these
children, are rising rapidly. In Hlabisa Hospital, KwaZulu-
Natal, 26% of children admitted to the paediatric medical
wards in 1997 were HIV-infected.'
Most HlV-infected children are infected by their mothers
during pregnancy, birth or through breast-feeding.' A costly,
complex regimen of zidovudine (ZDV) that excludes breast-
feeding (ACTG076) was found to reduce mother-ta-child HIV
transmission (MTCT) by 67%.' Adoption of this regimen, plus
safe obstetric practice, has virtually eliminated MTCT in some
developed countries.· A short, oral course of ZDV combined
with infant formula feeding in Thailand reduced MTCT by
51%/ and UNAIDS has recommended that developing
countries plan the implementation of programmes to reduce
MTCT8 Before effective implementation is possible, and if
maximum public health benefit is to be achieved, careful
planning is required.
We have presented data suggesting that only 11% of
expected paediatric HlV infections might be prevented if anti-
retroviral drugs are made available in the public sector within
current resource constraints in the Hlabisa district.' However,
with appropriate health system strengthening we estimated a
possible 37% reduction in HIY infections.' In the present paper
we apply our model to South Africa as a whole and to the nine
provinces, and use it to appraise the cost and cost effectiveness
of a ZDV intervention programme at these levels.
Conclusions. A national programme preventing 37% of
expected paediatric HIV infections would cost a small
fraction of the national health budget, at a cost equivalent to
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We first developed a detailed model for the Hlabisa health
district in KwaZulu- atal (population approximately 250 000,
antenatal HlV prevalence 26% in 1997) that used data from
several studies done in the district to estimate the possible
effect of interventions to reduce MTCT under different
scenarios.' We then applied this model to the whole of South
Africa. The annual number of pregnant women per province
and HIV prevalence in pregnant women per province were
taken from reports published by the national Department of
Health.' Applying an estimated MTCf rate of 30%,'· the
expected number of paediatric infections was estimated for
each province and the country as a whole for 1997, assuming
that there was no intervention to reduce MTCf in place at the
time.
Steps required to reduce vertical transmission
If a programme to reduce MTCf is to have maximal public
health impact, then several distinct steps are required:" (i) as
many pregnant women as possible must attend antenatal care
as early as pos~ible; (ii) as many women as possible must be
counselled about the potential intervention, tested for HIV
infection, receive test results and be counselled accordingly; (iii)
as many women as possible. must receive. the intervention and
be adherent to it; (iv) as many women as possible must deliver
either in hospital or clinic so that intra-partum anti-retroviral
drugs can be administered; (v) risk from breast-feeding should
be minimised as breast-feeding contributes approximately 30%
of the risk of vertical transmission; and (vi) paediatric follow-
up - in order to provide support and to assess the impact of
the intervention, the mother-child pair requires regular
assessment; it may be important to determine early in the
postnatal period whether the intervention has been successful
so as to guide further feeding practice decisions and because
the parents are likely to want to know.
As previously described for Hlabisa; it seems likely that
these steps cannot be achieved within current resource and
infrastructure constraints in much of South Africa. We therefore
modelled one possible national programme to reduce MTCT.
In this model ZDV is provided as in the Thai protocol.' We
assumed that substantial efforts are being made to enhance
service infrastructure, with the goal of improving programme
delivery." Enhancements include: Widespread health promotion
to encourage early attendance for antenatal care <jnd to inform
the community about the intervention available, on-site (rapid
test) HIV testing, extra staff to increase counselling capacity, an
assured drug supply, extra staff to provide a 24-hour maternity
service in all clinics, and avoidance of breast-feeding when safe
and feasible. Infant milk formula is provided for 4 months.
To estimate effectiveness we assumed that health promotion
is successful and that only 2.5% of pregnant women do not
attend antenatal care. Due to on-site HIV testing and increased
counselling capacity we assumed that 75% of women accept
testing, receive the result and receive the intervention. The
MTCf rate among these women is assumed to be 15% (50%
reduction). The remaining 25% do not receive ZDV and
experience a 30% MTCT rate"
Intervention costs
The cost analysis was undertaken from the perspective of the
health system. Each intervention component was costed
individually. Drug costs were based on those recently
announced for developing countries by Glaxo-Wellcome
(P Moore, Glaxo-Wellcome - personal communication), and
formula feed costs were estimated using government tender
prices (Dr G Gray, Perinatal HIV Research Unit - personal
communication). HIV test costs were based on existing market
quotes.
The cost of extra staff, training and health education were
estimated on a per pregnant woman screened basis, using the
model developed for Hlabisa" For example, the total cost of
extra counselling capacity required in Hlabisa was divided by
the number of women receiving counselling, and the cost of
extra midwives was divided by the numbers of women
receiving the ZDV intervention. Staff costs were based on gross
salary figures. The largest cost was for counselling. In the
Hlabisa model, it was assumed that professional nurses would
do the counselling" Since this seemed unrealistic for South
Africa as a whole (not enough extra nurses could be recruited),
in the national model we assumed that trained lay counsellors
would be used and that they would receive a salary 50% of that
paid to a nurse.
Calculation of cost effectiveness
Cost data were combined with our estimate of effectiveness to
calculate the cost per infection prevented. The number of
disability-adjusted life years (DALYs) gained per infection
prevented was calculated using a life expectancy of 69 years,
the average for South Africa in 199711 The DALY is a composite
measure that allows valid comparisons of the effectiveness of
different interventions. The cost per DALY was calculated by
dividing the cost per infection prevented by the number of
DALYs gained per infection prevented. lI
Sensitivity analysis
A sensitivity analysis was undertaken to determine the impact
that reduced programme effectiveness (25% reduction in the
number of paediatric HIV infections versus 37% reduction) and
life expectancy (49 years average life expectancy among HIV
uninfected children versus 69 years) would have on our
estimates.
RESULTS
Estimated number of paediatric HIV infections in
1997
As reflected in Table 1, the estimated number of paediatric HIV
infections by province for 1997, based on the estimated
prevalence of HIV infection among pregnant women and the
number of pregnancies, is highly variable. Most infections
occurred in KwaZulu- atal (18 513, 29%), Gauteng (l0 417,
16%) and the Eastern Cape (8 672,14%), with few in the
Western Cape (l 751,3%) and orthern Cape (558, 1%).
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Unit costs
7
2.4
4.3
35.8
300
240
13
13
Cost (rands)
Cost (rands) (%)
45 794 703 (29)
46 359 093 (30)
37087274 (24)
16861 974 (11)
6234 880 (4)
3530084 (2)
155 872 008 (100)
0.94
3.89
Programme component
Programme component
Table IL Unit costs of programme components
ZDV per woman
Infant milk formula (4 months)
Single rapid HIV test
Double ELISA HIV test
Single ELISA HIV test
Health promotion (per woman screened)
Training existing staff (per woman screened)
Extra counsellors, midwives and laboratory
technicians (per woman screened)
mv ~ zidovudine; EI..lSA = enzyme-linked immunosorbent assay.
Counsellor salaries
AntiretroViral drugs (zidovudine)
Infant milk formula
HIVtests
Training
Health promotion
Total
Total as %national health budget
Total as cost/capita (total
population)
Table Ill. Total and component costs of a national programme to
reduce mother-ta-child HIV transmission in South Africa
The unit costs of the various programme components are
reflected in Table II. Per woman screened, the greatest unit cost
is a course of ZDV (R300), followed by a 4-month supply of
infant milk formula. The cost of providing the extra staff and
human resource capacity required to run the programme is
estimated at R35.8 per woman screened.
As reflected in Tables I and Ill, the major programme costs are
salaries for counsellors (R45.8 million, 29%), antiretroviral
drugs (R46.4 million, 30%) and infant milk formula (R37.1
million, 24%). These costs vary substantially by province. For
example, staff costs and HIV test kit costs both depend
primarily on the number of pregnant women in a province,
and on the number who are screened. Drug costs and infant
formula costs primarily depend on prevalence of HIV infection
among pregnant women.
Total costs
We estimate the total cost of a national programme at
R155 872 008, equivalent to approximately 0.94% of the
national health budget. Provincial programme costs vary from
0.61% to 1.88% of provincial health budgets (Table 1).
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Cost effectiveness
Tationally, the cost per paediatric HN infection prevented is
estimated at R6 724. This figure varies from R~ 232 in
KwaZulu-Natal to Rll 656 in the Western Cape, reflecting the
efficiency of providing interventions in high-prevalence
settings. The cost per DALY gained is R213 nationally, varying
from RI34 in KwaZulu- atal to R369 in the Western Cape.
In our sensitivity analysis, assuming 25% reduction in the
number of infections rather than 37%, and assuming life
expectancy of 49 years rather than 69 years, the cost per
infection prevented is R9 830, and the cost per DALY gained is
R311, nationally.
We estimate that the cost of such a national programme is
equivalent to 0.94% of the national health budget12 and is
equivalent to an expenditure of R3.89 per person living in
South Africa.
DISCUSSION
This model suggests that a national programme to reduce
mother-to-child HN transmission in South Africa is potentially
affordable and cost effective. It would cost less than 1% of the
national health budget and the cost/DALY compares
favourably with figures for clinical and public health
interventions already in place. For example, when costed in
1990, the Expanded Program on Immunisation Plus
programme was estimated to cost US $25 - 30 per DALY
gained, and family planning was estimated to cost US $100 -
150 per DALY gained.13 However, there is substantial variation
in HIV prevalence across South Africa. The most efficient
approach might be to phase the implementation of any
programme, starting in high-prevalence settings such as
KwaZulu- ata!, Mpumalanga and Gauteng, since it is notable
that the intervention would be most cost effective in these
areas.
Limitations of the model
Modelling exercises of this nature are inherently limited. They
are dependent on available data from other studies and on
assumptions made about the applicability of these data to other
settings. We aimed to use the best available published data in
our modeL We used a published model' developed for Hlabisa
and extrapolated it to the rest of South Africa. Clearly, several
of the conditions that hold in Hlabisa will not hold precisely
elsewhere in the country. For example, the proportion of
women that attend for antenatal care may vary, the acceptance
of HIV counselling and testing and access to test results will
differ and the ease of ensuring a secure drug supply is also
likely to differ by site. As data on such variables are not
available for other sites in the country, the best we can do is to
state our assumptions explicitly, to modify them as new data
become available, and to make the model available to others
who wish to modify it.
We relied on population and fertility estimates based on the
1991 census, and while these may be too high, no revised data
were available from the 1996 census at the time of this study.
There is also no consideration given to activity in the private
sector. We found no published data on utilisation rates of
private sector obstetricians, HIV prevalence, or current
practice around MTCT interventions in the private sector. Costs
in the private sector are higher than in the public sector and
hence the total cost of a national programme is likely to be
higher than the cost we estimated here. However, private sector
utilisation will not affect the cost to the government of a
national public sector programme.
We may have overestimated the total cost of the programme.
In some urban and well-developed areas there may be little
need to strengthen health services with extra staff, extra clinics
and on-site HIV testing. In other, very remote and
underdeveloped areas, substantial extra effort and expenditure
may be needed to provide a reasonable service. Some of the
extra costs we considered, e.g. laboratory services and staff
time, might be shared across other activities and programmes
within the health service. Should the public sector pay for and
provide infant formula? While leaving the cost of formula to
mothers would substantially reduce programme costs from a
health service perspective, there would be a danger that
programme effectiveness might fall, as avoidance of breast-
feeding is a key component of the intervention.
It is also important to note that this modelling exercise has
not incorporated the savings to health service costs that a
MTCT programme would inevitably generate.
By averting HN infection among a large number of children,
costs associated with medical care for HIV-related problems
among HIV-infected children would fall. There are few data to
guide the size of these cost savings, but if the cost of medical
care per HN-infected child exceeds R6 724 (the cost of averting
an infection), then the intervention would actually be cost
saving. Data from elsewhere concerning the cost of care for
adults with AIDS suggest that it is conceivable that care costs
could be this high l ' One major problem in this modelling
exercise is that we have little idea about what these care costs
are likely to be in practice. It is therefore a priority to assess
them more thoroughly as they could make the case for a
national MTVT intervention both more convincing and more
accurate.
It is also important to raise the issue of the potentially
negative impact of bottle-feeding on the community, its health,
and the costs of health care. Most HIV-infected pregnant
women have HN-uninfected children, and although we cannot
identify who they will be, breast-feeding would remain their
preferred feeding choice. Similarly, there must be concern
about bottle-feeding, with its negative health consequences,
gaining favour among HIV-uninfected women.
It seems possible that provinces would develop programmes
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tailored towards their own needs. Some provinces with a very
low burden of HIV infection might not consider an MTCT
programme a priority. Some might not need to provide extra
staff or staff time for their programmes; others may choose to
provide infant milk formula for 6 months rather than 4 months.
Our model is simple and easy to use and interested parties are
encouraged to modify it and so estimate the costs and cost
effectiveness of programmes under different scenarios. As new
data become availablel,.l. they can also be used to modify the
model. This process is now underway.
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FROM POLICY TO PRAXIS - A
FRAMEWORK FOR THE DELIVERY
OF DISTRICT MENTAL HEALTH
CARE IN KWAZULU-NATAL
I Petersen, A Bhagwanjee, A Parekh
This article provides a schema for the provision of mental
health care at district level. A framework for service delivery
was derived from research conducted by the Community
~entalHealth Programme (CMHP) into the development of
aspects of a district mental health care system in a semi-rural
community area in KwaZulu-Natal. Furthennore,
infonnation was drawn from interviews with key
stakeholders, national and provincial policy documents as
well as international experience in the implementation of
community-based systems of mental health care.
5 Afr Med J2000; 90: 798-804.
The implementation of a national health care system in South
Africa based on the principles of universal primary health care
necessitates an urgent restructuring of mental health care
services. Historically, the latter has existed as a vertical service
within the health care system, providing largely institutional
and curative care for the seriously mentally ill.' Current policy
imperatives, as contained within the White Paper on the
Transformation of the Health System in South Africa,'
emphasise the need for a shift towards a comprehensive and
community-based mental health care system that is integrated
with other primary care services and provided by
appropriately trained multidisciplinary health care teams.
Within this approach mental health care is conceptualised
broadly to include the promotion of the psychosocial well-
being of the population as a whole.
In line with these policy imperatives, this article provides a
schema for the delivery of district-based mental health care in
KwaZulu- latal. A framework has been developed that has
been infonned, in the first instance, by the work of the
Community Mental Health Programme (CMHP), which has
been involved in developing aspects of a district mental health
care system in the KwaDedangendlale community area in the
Deparhnent of Psychology, University of DlIrban-Westville, Durban
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